Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C26H28N4O3 |
Molecular Weight | 444.5255 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(CC[C@@H](CC2=CC=C(NC(=O)[C@@H]3CCC4=NC=CC(=O)N34)C=C2)N1)[C@H](O)C5=CC=CC=C5
InChI
InChIKey=DJXRIQMCROIRCZ-XOEOCAAJSA-N
InChI=1S/C26H28N4O3/c31-24-14-15-27-23-13-12-22(30(23)24)26(33)29-19-8-6-17(7-9-19)16-20-10-11-21(28-20)25(32)18-4-2-1-3-5-18/h1-9,14-15,20-22,25,28,32H,10-13,16H2,(H,29,33)/t20-,21+,22-,25+/m0/s1
Molecular Formula | C26H28N4O3 |
Molecular Weight | 444.5255 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 05:53:46 UTC 2023
by
admin
on
Sat Dec 16 05:53:46 UTC 2023
|
Record UNII |
M5TSE03W5U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C48149
Created by
admin on Sat Dec 16 05:53:46 UTC 2023 , Edited by admin on Sat Dec 16 05:53:46 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
M5TSE03W5U
Created by
admin on Sat Dec 16 05:53:46 UTC 2023 , Edited by admin on Sat Dec 16 05:53:46 UTC 2023
|
PRIMARY | |||
|
ZZ-39
Created by
admin on Sat Dec 16 05:53:46 UTC 2023 , Edited by admin on Sat Dec 16 05:53:46 UTC 2023
|
PRIMARY | |||
|
DTXSID40152299
Created by
admin on Sat Dec 16 05:53:46 UTC 2023 , Edited by admin on Sat Dec 16 05:53:46 UTC 2023
|
PRIMARY | |||
|
M5TSE03W5U
Created by
admin on Sat Dec 16 05:53:46 UTC 2023 , Edited by admin on Sat Dec 16 05:53:46 UTC 2023
|
PRIMARY | |||
|
2472254
Created by
admin on Sat Dec 16 05:53:46 UTC 2023 , Edited by admin on Sat Dec 16 05:53:46 UTC 2023
|
PRIMARY | |||
|
DB14895
Created by
admin on Sat Dec 16 05:53:46 UTC 2023 , Edited by admin on Sat Dec 16 05:53:46 UTC 2023
|
PRIMARY | |||
|
CHEMBL2107826
Created by
admin on Sat Dec 16 05:53:46 UTC 2023 , Edited by admin on Sat Dec 16 05:53:46 UTC 2023
|
PRIMARY | |||
|
100000174857
Created by
admin on Sat Dec 16 05:53:46 UTC 2023 , Edited by admin on Sat Dec 16 05:53:46 UTC 2023
|
PRIMARY | |||
|
9676
Created by
admin on Sat Dec 16 05:53:46 UTC 2023 , Edited by admin on Sat Dec 16 05:53:46 UTC 2023
|
PRIMARY | |||
|
5311
Created by
admin on Sat Dec 16 05:53:46 UTC 2023 , Edited by admin on Sat Dec 16 05:53:46 UTC 2023
|
PRIMARY | |||
|
1190389-15-1
Created by
admin on Sat Dec 16 05:53:46 UTC 2023 , Edited by admin on Sat Dec 16 05:53:46 UTC 2023
|
PRIMARY | |||
|
142418
Created by
admin on Sat Dec 16 05:53:46 UTC 2023 , Edited by admin on Sat Dec 16 05:53:46 UTC 2023
|
PRIMARY | |||
|
C152872
Created by
admin on Sat Dec 16 05:53:46 UTC 2023 , Edited by admin on Sat Dec 16 05:53:46 UTC 2023
|
PRIMARY | |||
|
Vibegron
Created by
admin on Sat Dec 16 05:53:46 UTC 2023 , Edited by admin on Sat Dec 16 05:53:46 UTC 2023
|
PRIMARY | |||
|
44472635
Created by
admin on Sat Dec 16 05:53:46 UTC 2023 , Edited by admin on Sat Dec 16 05:53:46 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
TRANSPORTER -> SUBSTRATE |
|
||
|
TARGET -> AGONIST |
SELECTIVE
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
EXCRETED UNCHANGED |
FECAL
|
||
|
EXCRETED UNCHANGED |
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Tmax | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
blood-to-plasma ratio | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||